0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic and Analgesic Drugs Market Research Report 2026
Published Date: 2026-04-24
|
Report Code: QYRE-Auto-25O12872
Home | Market Reports
Global Antipyretic and Analgesic Drugs Market Research Report 2023
BUY CHAPTERS

Global Antipyretic and Analgesic Drugs Market Research Report 2026

Code: QYRE-Auto-25O12872
Report
2026-04-24
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic and Analgesic Drugs Market Size

The global Antipyretic and Analgesic Drugs market was valued at US$ 14820 million in 2025 and is anticipated to reach US$ 17670 million by 2032, at a CAGR of 2.6% from 2026 to 2032.

Antipyretic and Analgesic Drugs Market

Antipyretic and Analgesic Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antipyretic and Analgesic Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Antipyretic and analgesic drugs are drugs that can restore the body temperature of patients with fever to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but their intensity is not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylates, anilines, and pyrazolones based on their chemical structure. Except for anilines, all of these drugs have anti-rheumatic effects and can also treat rheumatism and rheumatoid arthritis. This report covers the market for active pharmaceutical ingredients (APIs) for antipyretic and analgesic drugs. In 2024, global Antipyretic and analgesic drugs production reached approximately Antipyretic and analgesic drugs 360.79 K MT, with an average global market price of around US$ 42.01 per kg.
China and India are two major producers of antipyretic and analgesic drugs, accounting for 51.32% and 18.42% of the market share, respectively, in 2024. China is expected to maintain the fastest growth rate in the coming years, with its share projected to reach 54.06% by 2031. China has sufficient production capacity for antipyretic and analgesic drugs and is actively expanding into the international market. Its global share is expected to gradually increase by 2031. In terms of product type, paracetamol holds a significant position, with a projected share of 42.16% by 2031. At the same time, in terms of application, the share of adults in 2024 will be approximately 75.37%, and the CAGR in the next few years will be approximately 2.49%.
This report delivers a comprehensive overview of the global Antipyretic and Analgesic Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antipyretic and Analgesic Drugs. The Antipyretic and Analgesic Drugs market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antipyretic and Analgesic Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antipyretic and Analgesic Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Antipyretic and Analgesic Drugs Market Report

Report Metric Details
Report Name Antipyretic and Analgesic Drugs Market
Accounted market size in 2025 US$ 14820 million
Forecasted market size in 2032 US$ 17670 million
CAGR 2.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Oxapzin
  • Dexibuprofen
  • Anagen
  • Others
by Application
  • Aldult
  • Child
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Xinhua Pharmaceutical Company Limited, Mallinckrodt Pharmaceuticals, Jiheng Pharmaceutical Co., Ltd, Lu'an Pharmaceutical Co., Ltd., BASF, Seqens, IOL, Granules India, Wuyao Pharmaceutical Co., Ltd, Biocause Heilen Pharmaceutical Co., Ltd, Kangle Pharmaceutical CO., LTD, Fengyuan Pharmaceutical Co., Ltd., Haisen Pharmaceutical Co., Ltd, Jingye Medical Technology Co., Ltd, Liaoyuan Baikang Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Antipyretic and Analgesic Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Antipyretic and Analgesic Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Antipyretic and Analgesic Drugs Market growing?

Ans: The Antipyretic and Analgesic Drugs Market witnessing a CAGR of 2.6% during the forecast period 2026-2032.

What is the Antipyretic and Analgesic Drugs Market size in 2032?

Ans: The Antipyretic and Analgesic Drugs Market size in 2032 will be US$ 17670 million.

What is the Antipyretic and Analgesic Drugs Market share by region?

Ans: China and India are two major producers of antipyretic and analgesic drugs, accounting for 51.32% and 18.42% of the market share, respectively, in 2024.

What is the Antipyretic and Analgesic Drugs Market share by type?

Ans: In terms of product type, paracetamol holds a significant position, with a projected share of 42.16% by 2031.

Who are the main players in the Antipyretic and Analgesic Drugs Market report?

Ans: The main players in the Antipyretic and Analgesic Drugs Market are Xinhua Pharmaceutical Company Limited, Mallinckrodt Pharmaceuticals, Jiheng Pharmaceutical Co., Ltd, Lu'an Pharmaceutical Co., Ltd., BASF, Seqens, IOL, Granules India, Wuyao Pharmaceutical Co., Ltd, Biocause Heilen Pharmaceutical Co., Ltd, Kangle Pharmaceutical CO., LTD, Fengyuan Pharmaceutical Co., Ltd., Haisen Pharmaceutical Co., Ltd, Jingye Medical Technology Co., Ltd, Liaoyuan Baikang Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Antipyretic and Analgesic Drugs Market report?

Ans: The Applications covered in the Antipyretic and Analgesic Drugs Market report are Aldult, Child

What are the Type segmentation covered in the Antipyretic and Analgesic Drugs Market report?

Ans: The Types covered in the Antipyretic and Analgesic Drugs Market report are Paracetamol, Aspirin, Ibuprofen, Naproxen, Diclofenac, Oxapzin, Dexibuprofen, Anagen, Others

1 Antipyretic and Analgesic Drugs Market Overview
1.1 Product Definition
1.2 Antipyretic and Analgesic Drugs by Type
1.2.1 Global Antipyretic and Analgesic Drugs Market Value by Type: 2025 vs 2032
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxapzin
1.2.8 Dexibuprofen
1.2.9 Anagen
1.2.10 Others
1.3 Antipyretic and Analgesic Drugs by Application
1.3.1 Global Antipyretic and Analgesic Drugs Market Value by Application: 2025 vs 2032
1.3.2 Aldult
1.3.3 Child
1.4 Global Antipyretic and Analgesic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antipyretic and Analgesic Drugs Revenue 2021–2032
1.4.2 Global Antipyretic and Analgesic Drugs Sales 2021–2032
1.4.3 Global Antipyretic and Analgesic Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antipyretic and Analgesic Drugs Market Competition by Manufacturers
2.1 Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antipyretic and Analgesic Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Entry into the Industry
2.8 Global Antipyretic and Analgesic Drugs Market Competitive Situation and Trends
2.8.1 Global Antipyretic and Analgesic Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antipyretic and Analgesic Drugs Players Market Share by Revenue
2.8.3 Global Antipyretic and Analgesic Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antipyretic and Analgesic Drugs Market Scenario by Region
3.1 Global Antipyretic and Analgesic Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2021–2032
3.2.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021–2026
3.2.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2027–2032
3.3 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021–2032
3.3.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021–2026
3.3.2 Global Antipyretic and Analgesic Drugs Revenue by Region: 2027–2032
3.4 North America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.4.1 North America Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.4.3 North America Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.5.1 Europe Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.5.3 Europe Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic and Analgesic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.7.1 Latin America Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.7.3 Latin America Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021–2032)
4.1.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021–2026)
4.1.2 Global Antipyretic and Analgesic Drugs Sales by Type (2027–2032)
4.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021–2032)
4.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2021–2032)
4.2.1 Global Antipyretic and Analgesic Drugs Revenue by Type (2021–2026)
4.2.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2027–2032)
4.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Antipyretic and Analgesic Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021–2032)
5.1.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021–2026)
5.1.2 Global Antipyretic and Analgesic Drugs Sales by Application (2027–2032)
5.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021–2032)
5.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2021–2032)
5.2.1 Global Antipyretic and Analgesic Drugs Revenue by Application (2021–2026)
5.2.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2027–2032)
5.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Antipyretic and Analgesic Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Xinhua Pharmaceutical Company Limited
6.1.1 Xinhua Pharmaceutical Company Limited Company Information
6.1.2 Xinhua Pharmaceutical Company Limited Description and Business Overview
6.1.3 Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Product Portfolio
6.1.5 Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.2 Mallinckrodt Pharmaceuticals
6.2.1 Mallinckrodt Pharmaceuticals Company Information
6.2.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.2.3 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Product Portfolio
6.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.3 Jiheng Pharmaceutical Co., Ltd
6.3.1 Jiheng Pharmaceutical Co., Ltd Company Information
6.3.2 Jiheng Pharmaceutical Co., Ltd Description and Business Overview
6.3.3 Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.3.5 Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
6.4 Lu'an Pharmaceutical Co., Ltd.
6.4.1 Lu'an Pharmaceutical Co., Ltd. Company Information
6.4.2 Lu'an Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product Portfolio
6.4.5 Lu'an Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BASF Antipyretic and Analgesic Drugs Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Seqens
6.6.1 Seqens Company Information
6.6.2 Seqens Description and Business Overview
6.6.3 Seqens Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Seqens Antipyretic and Analgesic Drugs Product Portfolio
6.6.5 Seqens Recent Developments/Updates
6.7 IOL
6.7.1 IOL Company Information
6.7.2 IOL Description and Business Overview
6.7.3 IOL Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 IOL Antipyretic and Analgesic Drugs Product Portfolio
6.7.5 IOL Recent Developments/Updates
6.8 Granules India
6.8.1 Granules India Company Information
6.8.2 Granules India Description and Business Overview
6.8.3 Granules India Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Granules India Antipyretic and Analgesic Drugs Product Portfolio
6.8.5 Granules India Recent Developments/Updates
6.9 Wuyao Pharmaceutical Co., Ltd
6.9.1 Wuyao Pharmaceutical Co., Ltd Company Information
6.9.2 Wuyao Pharmaceutical Co., Ltd Description and Business Overview
6.9.3 Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.9.5 Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
6.10 Biocause Heilen Pharmaceutical Co., Ltd
6.10.1 Biocause Heilen Pharmaceutical Co., Ltd Company Information
6.10.2 Biocause Heilen Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.10.5 Biocause Heilen Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 Kangle Pharmaceutical CO., LTD
6.11.1 Kangle Pharmaceutical CO., LTD Company Information
6.11.2 Kangle Pharmaceutical CO., LTD Description and Business Overview
6.11.3 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Product Portfolio
6.11.5 Kangle Pharmaceutical CO., LTD Recent Developments/Updates
6.12 Fengyuan Pharmaceutical Co., Ltd.
6.12.1 Fengyuan Pharmaceutical Co., Ltd. Company Information
6.12.2 Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product Portfolio
6.12.5 Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Haisen Pharmaceutical Co., Ltd
6.13.1 Haisen Pharmaceutical Co., Ltd Company Information
6.13.2 Haisen Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.13.5 Haisen Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Jingye Medical Technology Co., Ltd
6.14.1 Jingye Medical Technology Co., Ltd Company Information
6.14.2 Jingye Medical Technology Co., Ltd Description and Business Overview
6.14.3 Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.14.5 Jingye Medical Technology Co., Ltd Recent Developments/Updates
6.15 Liaoyuan Baikang Pharmaceutical Co., Ltd
6.15.1 Liaoyuan Baikang Pharmaceutical Co., Ltd Company Information
6.15.2 Liaoyuan Baikang Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.15.5 Liaoyuan Baikang Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic and Analgesic Drugs Industry Chain Analysis
7.2 Antipyretic and Analgesic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic and Analgesic Drugs Production Mode & Process Analysis
7.4 Antipyretic and Analgesic Drugs Sales and Marketing
7.4.1 Antipyretic and Analgesic Drugs Sales Channels
7.4.2 Antipyretic and Analgesic Drugs Distributors
7.5 Antipyretic and Analgesic Drugs Customer Analysis
8 Antipyretic and Analgesic Drugs Market Dynamics
8.1 Antipyretic and Analgesic Drugs Industry Trends
8.2 Antipyretic and Analgesic Drugs Market Drivers
8.3 Antipyretic and Analgesic Drugs Market Challenges
8.4 Antipyretic and Analgesic Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antipyretic and Analgesic Drugs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Antipyretic and Analgesic Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Antipyretic and Analgesic Drugs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Antipyretic and Analgesic Drugs Sales (K MT) of Key Manufacturers (2021–2026)
 Table 5. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Antipyretic and Analgesic Drugs Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Types and Applications
 Table 12. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antipyretic and Analgesic Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic and Analgesic Drugs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Antipyretic and Analgesic Drugs Sales by Region (K MT), 2021–2026
 Table 18. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021–2026)
 Table 19. Global Antipyretic and Analgesic Drugs Sales by Region (K MT), 2027–2032
 Table 20. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2027–2032)
 Table 21. Global Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021–2026)
 Table 23. Global Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2027–2032)
 Table 25. North America Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
 Table 27. North America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
 Table 28. North America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
 Table 32. Europe Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
 Table 33. Europe Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (K MT), 2021–2026
 Table 37. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (K MT), 2027–2032
 Table 38. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
 Table 42. Latin America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
 Table 43. Latin America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
 Table 47. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
 Table 48. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Antipyretic and Analgesic Drugs Sales (K MT) by Type (2021–2026)
 Table 51. Global Antipyretic and Analgesic Drugs Sales (K MT) by Type (2027–2032)
 Table 52. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021–2026)
 Table 53. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2027–2032)
 Table 54. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021–2026)
 Table 57. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2027–2032)
 Table 58. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2021–2026)
 Table 59. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2027–2032)
 Table 60. Global Antipyretic and Analgesic Drugs Sales (K MT) by Application (2021–2026)
 Table 61. Global Antipyretic and Analgesic Drugs Sales (K MT) by Application (2027–2032)
 Table 62. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021–2026)
 Table 63. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2027–2032)
 Table 64. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021–2026)
 Table 67. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2027–2032)
 Table 68. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2021–2026)
 Table 69. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2027–2032)
 Table 70. Xinhua Pharmaceutical Company Limited Company Information
 Table 71. Xinhua Pharmaceutical Company Limited Description and Business Overview
 Table 72. Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Product
 Table 74. Xinhua Pharmaceutical Company Limited Recent Developments/Updates
 Table 75. Mallinckrodt Pharmaceuticals Company Information
 Table 76. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 77. Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Product
 Table 79. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 80. Jiheng Pharmaceutical Co., Ltd Company Information
 Table 81. Jiheng Pharmaceutical Co., Ltd Description and Business Overview
 Table 82. Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 84. Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 85. Lu'an Pharmaceutical Co., Ltd. Company Information
 Table 86. Lu'an Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product
 Table 89. Lu'an Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. BASF Company Information
 Table 91. BASF Description and Business Overview
 Table 92. BASF Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. BASF Antipyretic and Analgesic Drugs Product
 Table 94. BASF Recent Developments/Updates
 Table 95. Seqens Company Information
 Table 96. Seqens Description and Business Overview
 Table 97. Seqens Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Seqens Antipyretic and Analgesic Drugs Product
 Table 99. Seqens Recent Developments/Updates
 Table 100. IOL Company Information
 Table 101. IOL Description and Business Overview
 Table 102. IOL Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. IOL Antipyretic and Analgesic Drugs Product
 Table 104. IOL Recent Developments/Updates
 Table 105. Granules India Company Information
 Table 106. Granules India Description and Business Overview
 Table 107. Granules India Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. Granules India Antipyretic and Analgesic Drugs Product
 Table 109. Granules India Recent Developments/Updates
 Table 110. Wuyao Pharmaceutical Co., Ltd Company Information
 Table 111. Wuyao Pharmaceutical Co., Ltd Description and Business Overview
 Table 112. Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 114. Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 115. Biocause Heilen Pharmaceutical Co., Ltd Company Information
 Table 116. Biocause Heilen Pharmaceutical Co., Ltd Description and Business Overview
 Table 117. Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 119. Biocause Heilen Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 120. Kangle Pharmaceutical CO., LTD Company Information
 Table 121. Kangle Pharmaceutical CO., LTD Description and Business Overview
 Table 122. Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Product
 Table 124. Kangle Pharmaceutical CO., LTD Recent Developments/Updates
 Table 125. Fengyuan Pharmaceutical Co., Ltd. Company Information
 Table 126. Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product
 Table 129. Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Haisen Pharmaceutical Co., Ltd Company Information
 Table 131. Haisen Pharmaceutical Co., Ltd Description and Business Overview
 Table 132. Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 133. Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 134. Haisen Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 135. Jingye Medical Technology Co., Ltd Company Information
 Table 136. Jingye Medical Technology Co., Ltd Description and Business Overview
 Table 137. Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 138. Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 139. Jingye Medical Technology Co., Ltd Recent Developments/Updates
 Table 140. Liaoyuan Baikang Pharmaceutical Co., Ltd Company Information
 Table 141. Liaoyuan Baikang Pharmaceutical Co., Ltd Description and Business Overview
 Table 142. Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 143. Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
 Table 144. Liaoyuan Baikang Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Antipyretic and Analgesic Drugs Distributors List
 Table 148. Antipyretic and Analgesic Drugs Customers List
 Table 149. Antipyretic and Analgesic Drugs Market Trends
 Table 150. Antipyretic and Analgesic Drugs Market Drivers
 Table 151. Antipyretic and Analgesic Drugs Market Challenges
 Table 152. Antipyretic and Analgesic Drugs Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antipyretic and Analgesic Drugs
 Figure 2. Global Antipyretic and Analgesic Drugs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Antipyretic and Analgesic Drugs Market Share by Type: 2025 & 2032
 Figure 4. Paracetamol Product Picture
 Figure 5. Aspirin Product Picture
 Figure 6. Ibuprofen Product Picture
 Figure 7. Naproxen Product Picture
 Figure 8. Diclofenac Product Picture
 Figure 9. Oxapzin Product Picture
 Figure 10. Dexibuprofen Product Picture
 Figure 11. Anagen Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global Antipyretic and Analgesic Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 14. Global Antipyretic and Analgesic Drugs Market Share by Application: 2025 & 2032
 Figure 15. Aldult
 Figure 16. Child
 Figure 17. Global Antipyretic and Analgesic Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Antipyretic and Analgesic Drugs Market Size (US$ Million), 2021–2032
 Figure 19. Global Antipyretic and Analgesic Drugs Sales (K MT), 2021–2032
 Figure 20. Global Antipyretic and Analgesic Drugs Average Price (US$/kg), 2021–2032
 Figure 21. Antipyretic and Analgesic Drugs Report Years Considered
 Figure 22. Antipyretic and Analgesic Drugs Sales Share by Manufacturers in 2025
 Figure 23. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global Antipyretic and Analgesic Drugs Players: Market Share by Revenue in Antipyretic and Analgesic Drugs in 2025
 Figure 25. Antipyretic and Analgesic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
 Figure 28. North America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
 Figure 29. United States Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
 Figure 32. Europe Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
 Figure 33. Germany Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific Antipyretic and Analgesic Drugs Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021–2032)
 Figure 40. China Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. China Taiwan Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Southeast Asia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Antipyretic and Analgesic Drugs by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Type (2021–2032)
 Figure 59. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Antipyretic and Analgesic Drugs by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Application (2021–2032)
 Figure 62. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2021–2032)
 Figure 63. Antipyretic and Analgesic Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS